Riverview Capital Advisers’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-26,708
| Closed | -$886K | – | 85 |
|
|
2023
Q3 | $886K | Sell |
26,708
-200
| -0.7% | -$6.63K | 0.39% | 56 |
|
|
2023
Q2 | $987K | Buy |
26,908
+1,085
| +4% | +$39.8K | 0.43% | 51 |
|
|
2023
Q1 | $1.05M | Buy |
25,823
+43
| +0.2% | +$1.75K | 0.45% | 50 |
|
|
2022
Q4 | $1.32M | Buy |
25,780
+33
| +0.1% | +$1.69K | 0.71% | 34 |
|
|
2022
Q3 | $1.13M | Buy |
25,747
+36
| +0.1% | +$1.58K | 0.71% | 42 |
|
|
2022
Q2 | $1.35M | Buy |
25,711
+238
| +0.9% | +$12.5K | 0.75% | 39 |
|
|
2022
Q1 | $1.32M | Buy |
25,473
+941
| +4% | +$48.7K | 0.61% | 40 |
|
|
2021
Q4 | $1.45M | Buy |
+24,532
| New | +$1.45M | 0.64% | 39 |
|